Using integrated frontier and smart technologies to identify new drug targets for parasites causing major diseases in humans and animals

利用综合前沿和智能技术识别引起人类和动物重大疾病的寄生虫的新药物靶点

• 批准号: LX0882231
• 负责人: Prof Min Hu
• 金额: $ 6.2万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage - International
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-01-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LX0882231
• 关键词: Using; integrated; frontier; smart; technologies

The national/community benefits are (1) enhanced focus on animal and human health biotechnology through the development of anti-parasite compounds and/or vaccines; (2) improved and sustainable control of important parasites with decreased risk of induction of drug resistance; (3) increased profitability of agricultural animal production; (4) consolidation of a technology platform for further applications in genomics and post-genomics of pathogens of global significance and construction of a pipeline for the validation of drug targets; (5) capturing the benefits from fundamental research and strengthening links between fundamental and applied research; (6) increasing the quality and quantity of scientifically skilled people in biotechnology.

国家/社区的利益是：（1）通过开发抗寄生虫化合物和/或疫苗，加强对动物和人类健康生物技术的关注;（2）改善和可持续地控制重要的寄生虫，降低诱发抗药性的风险;（3）增加农业动物生产的利润;（4）巩固技术平台，以进一步应用于全球重要病原体的基因组学和后基因组学，并建立验证药物靶点的管道;（5）从基础研究中获益，加强基础研究与应用研究之间的联系;（6）提高生物技术领域科学技术人才的质量和数量。